Mumbai, Dec. 31 -- The proposed issuance will be within the limits already approved by the company's Board of Directors at its meeting held on 28 July 2025, the company said in an exchange filing.

Torrent Pharma is the flagship company of the Torrent Group. It is ranked 7th in the Indian Pharmaceuticals Market and is amongst the Top 5 in the therapeutics segments of Cardiovascular (CV), Gastro Intestinal (GI), Central Nervous System (CNS) and Cosmo-Dermatology. It is a specialty-focused company with

Published by HT Digital Content Services with permission from Capital Market....